Stattic Explained
| Image Class: | skin-invert-image |
| Class: | STAT3 inhibitor |
| Cas Number: | 19983-44-9 |
| Pubchem: | 2779853 |
| Chemspiderid: | 2060075 |
| Chebi: | 86989 |
| Chembl: | 1337170 |
| Iupac Name: | 6-nitro-1-benzothiophene 1,1-dioxide |
| C: | 8 |
| H: | 5 |
| N: | 1 |
| O: | 4 |
| S: | 1 |
| Smiles: | C1=CC(=CC2=C1C=CS2(=O)=O)[N+](=O)[O-] |
| Stdinchi: | 1S/C8H5NO4S/c10-9(11)7-2-1-6-3-4-14(12,13)8(6)5-7/h1-5H |
| Stdinchikey: | ZRRGOUHITGRLBA-UHFFFAOYSA-N |
Stattic is a drug that acts as an inhibitor of the transcription factor protein STAT3. It has potential applications in the treatment of cancer and autoimmune disorders.[1] [2] [3]
Notes and References
- Ko HJ, Kim YJ . Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer . Archives of Pharmacal Research . 39 . 11 . 1597–1608 . November 2016 . 27572156 . 10.1007/s12272-016-0822-9 .
- Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi FA, Kumer A, Tabrez S . STAT3 Signaling Pathway in Health and Disease . MedComm . 6 . 4 . e70152 . April 2025 . 40166646 . 10.1002/mco2.70152 . 11955304 .
- Wu Z, Lian G, He L, Hu P, Guo Y, Su Z . Targeting JAK-STAT signaling for autoimmune diseases: current understanding, clinical advances, and emerging directions . Immunology and Cell Biology . January 2026 . imcb.70078 . 41517955 . 10.1111/imcb.70078 .